Balyasny Asset Management
SPRY icon

Balyasny Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Balyasny Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$5.74M Buy
2025
Q1 		$2.15M Sell
2024
Q4 		$3.64M Buy
2024
Q3 		$327K Sell
2024
Q2 		$224K Sell
2024
Q1 		$311K Buy
2023
Q4 		$95.6K Buy
2023
Q1 		– Sell
2022
Q4 		$96.6K Buy